Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Androgenetic Alopecia (AGA) · Androgenetic Alopecia · AGA · Female Androgenetic Alopecia · Hair Loss

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Site 73, Birmingham, Alabama, United States

  • Site 89, Birmingham, Alabama, United States

  • Site 77, Phoenix, Arizona, United States

  • Site 30, Fort Smith, Arkansas, United States

  • Site 69, Encino, California, United States

  • Site 2, Fremont, California, United States

  • Site 64, Manhattan Beach, California, United States

  • Site 93, Northridge, California, United States

  • Site 66, Santa Monica, California, United States

  • Site 34, Sherman Oaks, California, United States

  • Site 94, Thousand Oaks, California, United States

  • Site 21, Vista, California, United States

  • Site 5, Castle Rock, Colorado, United States

  • Site 24, Greenwood Village, Colorado, United States

  • Site 17, Aventura, Florida, United States

  • Site 71, Boca Raton, Florida, United States

  • Site 86, Coral Gables, Florida, United States

  • Site 62, Coral Gables, Florida, United States

  • Site 99, Miami, Florida, United States

  • Site 54, Ocala, Florida, United States

  • Site 43, Atlanta, Georgia, United States

  • Site 90, Sandy Springs, Georgia, United States

  • Site 31, Boise, Idaho, United States

  • Site 61, Chicago, Illinois, United States

  • Site 53, Clarksville, Indiana, United States

  • Site 15, Indianapolis, Indiana, United States

  • Site 32, New Albany, Indiana, United States

  • Site 55, Plainfield, Indiana, United States

  • Site 27, West Lafayette, Indiana, United States

  • Site 79, Leawood, Kansas, United States

  • Site 52, Louisville, Kentucky, United States

  • Site 41, Baton Rouge, Louisiana, United States

  • Site 13, Covington, Louisiana, United States

  • Site 12, Metairie, Louisiana, United States

  • Site 75, New Orleans, Louisiana, United States

  • Site 84, Glenn Dale, Maryland, United States

  • Site 87, Rockville, Maryland, United States

  • Site 22, Brighton, Massachusetts, United States

  • Site 80, Chestnut Hill, Massachusetts, United States

  • Site 59, Quincy, Massachusetts, United States

  • Site 26, Clarkston, Michigan, United States

  • Site 68, Clinton Township, Michigan, United States

  • Site 83, Southfield, Michigan, United States

  • Site 98, Medina, Minnesota, United States

  • Site 56, Minneapolis, Minnesota, United States

  • Site 6, New Brighton, Minnesota, United States

  • Site 18, Hackensack, New Jersey, United States

  • Site 37, Kew Gardens, New York, United States

  • Site 97, New York, New York, United States

  • Site 82, Hickory, North Carolina, United States

  • Site 92, Huntersville, North Carolina, United States

  • Site 39, Boardman, Ohio, United States

  • Site 72, Cincinnati, Ohio, United States

  • Site 11, Columbus, Ohio, United States

  • Site 57, Portland, Oregon, United States

  • Site 60, Anderson, South Carolina, United States

  • Site 95, Hermitage, Tennessee, United States

  • Site 9, Knoxville, Tennessee, United States

  • Site 4, Nashville, Tennessee, United States

  • Site 76, Austin, Texas, United States

  • Site 74, College Station, Texas, United States

  • Site 67, Dallas, Texas, United States

  • Site 14, Houston, Texas, United States

  • Site 88, San Antonio, Texas, United States

  • Site 91, Sugar Land, Texas, United States

  • Site 19, South Jordan, Utah, United States

  • Site 29, Forest, Virginia, United States

  • Site 63, Norfolk, Virginia, United States

  • Site 85, Norfolk, Virginia, United States

  • Site 33, Burien, Washington, United States

  • Site 70, Mill Creek, Washington, United States

מובילי המחקר
  • Reid Waldman, M.D.

    Study Chair

    Veradermics, Inc.

  • Timothy Durso, M.D.

    Study Chair

    Veradermics, Inc.